Drug intelligence / Profile preview

ácido acetilsalicílico + cafeína + tiamina clorhidrato

Development stage
Unknown
Lead developer
Laboratorios Combix
Modality
Small Molecules
Administration
Oral
01

Overview

ácido acetilsalicílico + cafeína + tiamina clorhidrato (marketed under the brand name Calmante Vitaminado Perezgiménez) is an over-the-counter (OTC) fixed-dose combination analgesic and antipyretic. Originally developed by Laboratorios Pérez Giménez in 1954, the product was later acquired by Pharmex Advanced Laboratories in 2015 and is currently marketed by Laboratorios Combix (a subsidiary of Zydus Lifesciences). Each tablet contains 500 mg of acetylsalicylic acid (aspirin), 50 mg of caffeine, and 2 mg of thiamine hydrochloride (Vitamin B1). It is indicated for the symptomatic relief of mild to moderate occasional pain, such as headaches, dental pain, menstrual pain, muscle contractures, and back pain (lumbago), as well as febrile states. The combination leverages the anti-inflammatory and analgesic properties of acetylsalicylic acid (via cyclooxygenase inhibition), the analgesic-adjuvant and stimulant effects of caffeine (via adenosine receptor antagonism), and the metabolic support of thiamine hydrochloride.

Brand names
Calmante VitaminadoCalmante Vitaminado PerezgiménezCalmante Vitaminado Pérez Giménez
Other names
acetylsalicylic acid + caffeine + thiamineacetylsalicylic acid + caffeine + thiamine hydrochlorideacetylsalicylic acid + caffeine + vitamin b1aspirin + caffeine + thiamineaspirin + caffeine + thiamine hydrochlorideaspirin + caffeine + vitamin b1ácido acetilsalicílico + cafeína + tiaminaácido acetilsalicílico + cafeína + vitamina b1
02

Targets

THTR (Thiamine transporter 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TPK1 (Thiamine pyrophosphokinase 1)ADORA2A (Adenosine A₂A Receptor)PGHS-1 (Prostaglandin G/H Synthase 1)ADORA3 (Adenosine A3 receptor)ADORA1 (Adenosine receptor A1 subtype)ADORA2B (Adenosine A2B receptor)

Beyond the preview

Go deeper on ácido acetilsalicílico + cafeína + tiamina clorhidrato.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ácido acetilsalicílico + cafeína + tiamina clorhidrato.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call